{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T15:39:35Z","timestamp":1793547575695,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","seizure-journal.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.seizure.2023.07.022","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T17:53:35Z","timestamp":1690566815000},"page":"98-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Early and established status epilepticus: The impact of timing of intervention, treatment escalation and dosing on outcome"],"prefix":"10.1016","volume":"111","author":[{"given":"Malaika","family":"Jindal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3390-5589","authenticated-orcid":false,"given":"Aidan","family":"Neligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9286-7696","authenticated-orcid":false,"given":"Sanjeev","family":"Rajakulendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2023.07.022_bib0001","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaneurol.2015.0188","article-title":"Trends in status epilepticus-related hospitalizations and mortality: redefined in US practice over time","volume":"72","author":"Betjemann","year":"2015","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.seizure.2023.07.022_bib0002","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1528-1167.2009.02040.x","article-title":"The history of status epilepticus and its treatment","volume":"50","author":"Neligan","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2023.07.022_bib0003","doi-asserted-by":"crossref","first-page":"e1393","DOI":"10.1212\/WNL.0000000000200912","article-title":"Mortality, disability, and prognostic factors of status epilepticus: a nationwide population-based retrospective cohort study","volume":"99","author":"Choi","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2023.07.022_bib0004","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the american epilepsy society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.seizure.2023.07.022_bib0005","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s40263-022-00940-2","article-title":"Benzodiazepines in the management of seizures and status epilepticus: a review of routes of delivery, pharmacokinetics, efficacy, and tolerability","volume":"36","author":"Kienitz","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2023.07.022_bib0006","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","article-title":"Randomized trial of three anticonvulsant medications for status epilepticus","volume":"381","author":"Kapur","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2023.07.022_bib0007","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/brain\/awab049","article-title":"Advances in the management of generalized convulsive status epilepticus: what have we learned?","volume":"144","author":"Neligan","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2023.07.022_bib0008","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(19)30724-X","article-title":"Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial","volume":"393","author":"Lyttle","year":"2019","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.seizure.2023.07.022_bib0009","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/S0140-6736(19)30722-6","article-title":"Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial","volume":"393","author":"Dalziel","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2023.07.022_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/ana.25416","article-title":"Factors predicting cessation of status epilepticus in clinical practice: data from a prospective observational registry (SENSE)","author":"Kellinghaus","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2023.07.022_bib0011","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1111\/epi.16289","article-title":"The difficulty of diagnosing NCSE in clinical practice; external validation of the Salzburg criteria","volume":"60","author":"Goselink","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2023.07.022_bib0012","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus","volume":"339","author":"Treiman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2023.07.022_bib0013","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa002141","article-title":"A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus","volume":"345","author":"Alldredge","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2023.07.022_bib0014","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1523\/JNEUROSCI.0900-05.2005","article-title":"Status epilepticus increases the intracellular accumulation of GABAA receptors","volume":"25","author":"Goodkin","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.seizure.2023.07.022_bib0015","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA A receptors, loss of inhibition, and a mechanism for Pharmacoresistance in status Epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.seizure.2023.07.022_bib0016","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus - report of the ILAE task force on classification of status epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2023.07.022_bib0017","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1212\/WNL.0000000000001673","article-title":"Time from convulsive status epilepticus onset to anticonvulsant administration in children","volume":"84","author":"Sanchez Fernandez","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2023.07.022_bib0018","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/epi.12526","article-title":"Emergency management of febrile status epilepticus: results of the FEBSTAT study","volume":"55","author":"Seinfeld","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2023.07.022_bib0019","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.seizure.2017.10.007","article-title":"Rescue medications in epilepsy patients: a family perspective","volume":"52","author":"Ga\u00ednza-Lein","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2023.07.022_bib0020","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/epi.16825","article-title":"Patterns of benzodiazepine underdosing in the established status epilepticus treatment trial","volume":"62","author":"Sathe","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2023.07.022_bib0021","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/acem.13811","article-title":"Underdosing of benzodiazepines in patients with status epilepticus enrolled in established status epilepticus treatment trial","volume":"26","author":"Sathe","year":"2019","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.seizure.2023.07.022_bib0022","doi-asserted-by":"crossref","first-page":"e2683","DOI":"10.1212\/WNL.0000000000010828","article-title":"First-line medication dosing in pediatric refractory status epilepticus","volume":"95","author":"Vasquez","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2023.07.022_bib0023","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1684\/epd.2018.0987","article-title":"Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus","volume":"20","author":"Rao","year":"2018","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.seizure.2023.07.022_bib0024","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/j.1528-1167.2010.02688.x","article-title":"Generalized convulsive status epilepticus management in adults: a cohort study with evaluation of professional practice","volume":"51","author":"Aranda","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2023.07.022_bib0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/epi.12284","article-title":"Lessons from the RAMPART study-and which is the best route of administration of benzodiazepines in status epilepticus","volume":"54","author":"Silbergleit","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2023.07.022_bib0026","doi-asserted-by":"crossref","first-page":"e3203","DOI":"10.1212\/WNL.0000000000010913","article-title":"Prehospital midazolam use and outcomes among patients with out-of-hospital status epilepticus","volume":"95","author":"Guterman","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2023.07.022_bib0027","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.yebeh.2015.02.030","article-title":"Nonintravenous midazolam versus intravenous or rectal diazepam for the treatment of early status epilepticus: a systematic review with meta-analysis","volume":"49","author":"Brigo","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2023.07.022_bib0028","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1553-2712.2010.00751.x","article-title":"Midazolam Versus Diazepam for the Treatment of Status Epilepticus in Children and Young Adults: a Meta-analysis","volume":"17","author":"McMullan","year":"2010","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.seizure.2023.07.022_bib0029","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003723.pub3","article-title":"Anticonvulsant therapy for status epilepticus","author":"Prasad","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.seizure.2023.07.022_bib0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.seizure.2018.05.021","article-title":"Timing in the treatment of status epilepticus: from basics to the clinic","volume":"68","author":"Ga\u00ednza-Lein","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2023.07.022_bib0031","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eplepsyres.2018.10.014","article-title":"Timing and selection of first antiseizure medication in patients with pediatric status epilepticus","volume":"149","author":"Cohen","year":"2019","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2023.07.022_bib0032","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0197-2456(01)00120-9","article-title":"The prehospital treatment of status epilepticus (PHTSE) study","volume":"22","author":"Lowenstein","year":"2001","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.seizure.2023.07.022_bib0033","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1742-6723.2006.00807.x","article-title":"When benzodiazepines fail: how effective is second line therapy for status epilepticus in children?","volume":"18","author":"Lewena","year":"2006","journal-title":"Emerg Med Australas"},{"key":"10.1016\/j.seizure.2023.07.022_bib0034","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.seizure.2020.03.002","article-title":"Levetiracetam versus phenytoin for the treatment of established status epilepticus: a systematic review and meta-analysis of randomized controlled trials","volume":"78","author":"Li","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2023.07.022_bib0035","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.seizure.2021.07.012","article-title":"Efficacy and safety of levetiracetam versus (fos)phenytoin for second-line treatment of epilepticus: a meta-analysis of latest randomized controlled trials","volume":"91","author":"Feng","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2023.07.022_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107286","article-title":"Levetiracetam vs. phenytoin as 2nd-line treatment for status epilepticus: a systematic review and meta-analysis","volume":"111","author":"DeMott","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2023.07.022_bib0037","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/epi.13056","article-title":"Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: a multicenter comparison","volume":"56","author":"Alvarez","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2023.07.022_bib0038","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/practneurol-2021-003217","article-title":"Challenge to levetiracetam's de facto position as generic first-line antiseizure medication","volume":"22","author":"Neligan","year":"2022","journal-title":"Pract Neurol"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913112300211X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913112300211X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T06:56:26Z","timestamp":1728024986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105913112300211X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":38,"alternative-id":["S105913112300211X"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2023.07.022","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early and established status epilepticus: The impact of timing of intervention, treatment escalation and dosing on outcome","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2023.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd on behalf of British Epilepsy Association.","name":"copyright","label":"Copyright"}]}}